Annual report pursuant to Section 13 and 15(d)

Acquisitions (Tables)

v3.23.2
Acquisitions (Tables)
12 Months Ended
Jun. 30, 2023
Namocell Inc  
Notes Tables  
Schedule of the aggregate purchase price of the acquisitions that was allocated to the assets acquired and liabilities assumed

    

Preliminary allocation at acquisition date

Adjustments to fair value

Final allocation at June 30, 2023

Current assets, net of cash

$

3,248

$

$

3,248

Equipment and other long-term assets

 

405

 

405

Intangible assets:

Developed technologies

 

73,900

 

73,900

Tradenames

 

700

 

700

Customer relationships

 

900

 

900

Non-competition agreement

 

100

 

100

Goodwill

 

51,051

206

 

51,257

Total assets acquired

 

130,304

206

 

130,510

Liabilities

 

546

 

546

Deferred income taxes, net

 

17,974

206

 

18,180

Net assets acquired

$

111,784

$

$

111,784

Cash paid, net of cash acquired

 

101,184

 

101,184

Contingent consideration payable

 

10,600

 

10,600

Net assets acquired

$

111,784

$

$

111,784

Asuragen, Inc.  
Notes Tables  
Schedule of the aggregate purchase price of the acquisitions that was allocated to the assets acquired and liabilities assumed

The aggregate purchase price of the acquisitions was allocated to the assets acquired and liabilities assumed based on their fair values as of the acquisition date. The following table summarizes the fair values of the assets acquired and liabilities assumed for the fiscal year 2021 acquisitions (in thousands):

Asuragen

Eminence

Current assets, net of cash

$

10,422

$

3,145

Equipment and other long-term assets

 

3,762

1,639

Intangible assets:

  

Developed technology

 

107,000

6,778

In-process research and development

 

22,700

Customer relationships

 

11,700

2,133

Trade names

 

2,000

Non-competition agreement

 

1,000

Goodwill

 

90,563

7,848

Total assets acquired

 

249,147

21,543

Liabilities

 

4,963

1,436

Deferred income taxes, net

 

10,297

1,357

Net assets acquired

$

233,887

$

18,750

Cash paid, net of cash acquired

 

215,587

9,765

Contingent consideration payable

 

18,300

8,985

Net assets acquired

$

233,887

$

18,750